Evidence map›Paper›PMID 32148417›Full record

ArticleJournal of ginseng research2020

Stereoisomer-specific ginsenoside 20(

Kyeong-Eun Yang, Hyun-Jin Jang, In-Hu Hwang, Eun Mi Hong, Min-Goo Lee, Soon Lee, Ik-Soon Jang, Jong-Soon Choi

Open access · goldAbstract read
In one paragraph

Article in Journal of ginseng research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Ambient PMEnvironment & health (Washington, D.C.) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Activation of CaClinical and translational medicine · 2021
    Article
  17. Article
  18. Article
  19. Effect of Antioxidants on the Fibroblast Replicative LifespanOxidative medicine and cellular longevity · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kyeong-Eun YangBiological Disaster Analysis Group, Korea Basic Science Institute, Daejeon, Republic of Korea.
Hyun-Jin JangBiological Disaster Analysis Group, Korea Basic Science Institute, Daejeon, Republic of Korea.
In-Hu HwangNeuroscience Research institute, Korea University College of Medicine, Seoul, Republic of Korea.
Eun Mi HongBiological Disaster Analysis Group, Korea Basic Science Institute, Daejeon, Republic of Korea.
Min-Goo LeeDepartment of Physiology, Korea University College of Medicine, Seoul, Republic of Korea.
Soon LeeDivision of Bio-Analytical Science, University of Science and Technology, Daejeon, Republic of Korea.
Ik-Soon JangBiological Disaster Analysis Group, Korea Basic Science Institute, Daejeon, Republic of Korea.
Jong-Soon ChoiBiological Disaster Analysis Group, Korea Basic Science Institute, Daejeon, Republic of Korea.
Korea Basic Science Institute · KRKorea University · KRKorea University of Science and Technology · KRChungnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe replicative senescence of human dermal fibroblasts (HDFs) is accompanied by growth arrest. In our previous study, the treatment of senescent HDFs with Rg3(

methodsWe performed senescence-associated β-galactosidase and cell cycle assays in Rg3(

resultsGinsenoside Rg3(

conclusionCellular molecular analysis suggests that Rg3(

Indexed as

Akt-mTOR-sirtuin signalingGinsenoside Rg3(S)Human dermal fibroblastReversalsenescence

Identifiers

PMID32148417
PMCPMC7031753
OpenAlexW2968393029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.